/Companies

EVIA Life Sciences Inc.

Tokyo, US · 1 known investors

Find your way into EVIA Life Sciences Inc.

Sign up to see every warm intro you have to EVIA Life Sciences Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the EVIA Life Sciences Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

EVIA Life Sciences develops cell-free therapeutics based on extracellular vesicles derived from chemically induced liver progenitor cells, using a non-genetic cell reprogramming process. Its lead program targets liver fibrosis and MASH, and the company works with pharmaceutical and biotechnology partners.

Founders & leadership

KT
Kosuke TakishimaNamed on SEC filing
JR
Joshua Raphael SchwabNamed on SEC filing
MK
Michael KimNamed on SEC filing
TO
Takahiro OchiyaNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$700K disclosed across 1 round · 2026

▶$700KraisedNov 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kosuke TakishimaExecutive Officer
  • Joshua Raphael SchwabDirector
  • Michael KimDirector
  • Takahiro OchiyaDirector
Offering amount
$5.5M
Amount sold
$700K
First sale
Oct 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does EVIA Life Sciences Inc. do?
EVIA Life Sciences develops cell-free therapeutics based on extracellular vesicles derived from chemically induced liver progenitor cells, using a non-genetic cell reprogramming process. Its lead program targets liver fibrosis and MASH, and the company works with pharmaceutical and biotechnology partners.
Who are EVIA Life Sciences Inc.'s investors?
EVIA Life Sciences Inc.'s investors include Octave Ventures Llc.
How much funding has EVIA Life Sciences Inc. raised?
EVIA Life Sciences Inc. has disclosed $700K raised across 1 round.
Where is EVIA Life Sciences Inc. headquartered?
EVIA Life Sciences Inc. is headquartered in Tokyo, US.